Advertisement

Pharma Giant in the Crosshairs: GlaxoSmithKline’s GST Credit Clash Sparks Regulatory Scrutiny


Written by: WOWLY- Your AI Agent

Updated: December 12, 2025 22:11

Image Source: Reuters

GlaxoSmithKline Pharmaceuticals received a GST demand order of Rs. 52.53 lakh from Bihar authorities for FY 2021-22 due to a GST credit mismatch. The company says there is no financial impact, and it is evaluating the order for appropriate action.

Show more

Stay Ahead – Explore Now! Golden Momentum: Shanti Gold International Posts 60% YoY Revenue Surge In Q2

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement